Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Hofman, Paul [VerfasserIn]   i
 Ilié, M. [VerfasserIn]   i
 Chamorey, E. [VerfasserIn]   i
 Brest, P. [VerfasserIn]   i
 Schiappa, R. [VerfasserIn]   i
 Nakache, V. [VerfasserIn]   i
 Antoine, M. [VerfasserIn]   i
 Barberis, M. [VerfasserIn]   i
 Begueret, H. [VerfasserIn]   i
 Bibeau, F. [VerfasserIn]   i
 Bonnetaud, C. [VerfasserIn]   i
 Boström, P. [VerfasserIn]   i
 Brousset, P. [VerfasserIn]   i
 Bubendorf, L. [VerfasserIn]   i
 Carvalho, L. [VerfasserIn]   i
 Cathomas, G. [VerfasserIn]   i
 Cazes, A. [VerfasserIn]   i
 Chalabreysse, L. [VerfasserIn]   i
 Chenard, M. -P. [VerfasserIn]   i
 Copin, M. -C. [VerfasserIn]   i
 Côté, J. -F. [VerfasserIn]   i
 Damotte, D. [VerfasserIn]   i
 de Leval, L. [VerfasserIn]   i
 Delongova, P. [VerfasserIn]   i
 Thomas de Montpreville, V. [VerfasserIn]   i
 de Muret, A. [VerfasserIn]   i
 Dema, A. [VerfasserIn]   i
 Dietmaier, W. [VerfasserIn]   i
 Evert, M. [VerfasserIn]   i
 Fabre, A. [VerfasserIn]   i
 Forest, F. [VerfasserIn]   i
 Foulet, A. [VerfasserIn]   i
 Garcia, S. [VerfasserIn]   i
 Kriegsmann, Mark [VerfasserIn]   i
 Schirmacher, Peter [VerfasserIn]   i
 Stenzinger, Albrecht [VerfasserIn]   i
Titel:Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future
Verf.angabe:P. Hofman, M. Ilié, E. Chamorey, P. Brest, R. Schiappa, V. Nakache, M. Antoine, M. Barberis, H. Begueret, F. Bibeau, C. Bonnetaud, P. Boström, P. Brousset, L. Bubendorf, L. Carvalho, G. Cathomas, A. Cazes, L. Chalabreysse, M.-P. Chenard, M.-C. Copin, J.-F. Côté, D. Damotte, L. de Leval, P. Delongova, V. Thomas de Montpreville, A. de Muret, A. Dema, W. Dietmaier, M. Evert, A. Fabre, F. Forest, A. Foulet, S. Garcia, M. Garcia-Martos, L. Gibault, G. Gorkiewicz, D. Jonigk, J. Gosney, A. Hofman, I. Kern, K. Kerr, M. Kossai, M. Kriegsmann, S. Lassalle, E. Long-Mira, A. Lupo, A. Mamilos, R. Matěj, J. Meilleroux, C. Ortiz-Villalón, L. Panico, A. Panizo, M. Papotti, P. Pauwels, G. Pelosi, F. Penault-Llorca, O. Pop, N. Poté, S.R.Y. Cajal, J.-C. Sabourin, I. Salmon, M. Sajin, S. Savic-Prince, H.-U. Schildhaus, P. Schirmacher, I. Serre, E. Shaw, D. Sizaret, A. Stenzinger, J. Stojsic, E. Thunnissen, W. Timens, G. Troncone, C. Werlein, H. Wolff, J.-P. Berthet, J. Benzaquen, C.-H. Marquette, V. Hofman & F. Calabrese
E-Jahr:2021
Jahr:4 January 2021
Umfang:10 S.
Fussnoten:Gesehen am 24.07.2021
Titel Quelle:Enthalten in: ESMO open
Ort Quelle:London : BMJ, 2016
Jahr Quelle:2021
Band/Heft Quelle:6(2021), 1 vom: Jan., Artikel-ID 100024, Seite 1-10
ISSN Quelle:2059-7029
Abstract:Background - This study evaluated the consequences in Europe of the COVID-19 outbreak on pathology laboratories orientated toward the diagnosis of thoracic diseases. - Materials and methods - A survey was sent to 71 pathology laboratories from 21 European countries. The questionnaire requested information concerning the organization of biosafety, the clinical and molecular pathology, the biobanking, the workload, the associated research into COVID-19, and the organization of education and training during the COVID-19 crisis, from 15 March to 31 May 2020, compared with the same period in 2019. - Results - Questionnaires were returned from 53/71 (75%) laboratories from 18 European countries. The biosafety procedures were heterogeneous. The workload in clinical and molecular pathology decreased dramatically by 31% (range, 3%-55%) and 26% (range, 7%-62%), respectively. According to the professional category, between 28% and 41% of the staff members were not present in the laboratories but did teleworking. A total of 70% of the laboratories developed virtual meetings for the training of residents and junior pathologists. During the period of study, none of the staff members with confirmed COVID-19 became infected as a result of handling samples. - Conclusions - The COVID-19 pandemic has had a strong impact on most of the European pathology laboratories included in this study. Urgent implementation of several changes to the organization of most of these laboratories, notably to better harmonize biosafety procedures, was noted at the onset of the pandemic and maintained in the event of a new wave of infection occurring in Europe.
DOI:doi:10.1016/j.esmoop.2020.100024
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.1016/j.esmoop.2020.100024
 Volltext: https://www.sciencedirect.com/science/article/pii/S2059702920328891
 DOI: https://doi.org/10.1016/j.esmoop.2020.100024
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:activity
 biosafety
 COVID-19
 lung cancer
 pathology
K10plus-PPN:1764273400
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68762900   QR-Code
zum Seitenanfang